SC 13G

Company

Jasper Therapeutics, Inc.

Filed

October 10, 2023

Accession Number

0001178913-23-003298

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →